Eli Lilly has axed a Phase IIb obesity clinical trial involving its blockbuster weight loss and type 2 diabetes (T2D) drug glucagon-like peptide-1 receptor agonist (GLP-1RA) in combination with an ...
The RXT-1 or RefleX Trainer-1, was conceived, designed and built at home by former Army Special Forces Sgt. 1st Class Brent Verdialez after he sustained a wrist injury that prevent him from sparring. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback